![Committee On Clinical Trial Registries; Board On Health Sciences Policy; Institute Of Medicine; National Academy Of Sciences - Developing a National Registry of Pharmacologic and Biologic Clinical Trials - 9780309100786 - V9780309100786 Committee On Clinical Trial Registries; Board On Health Sciences Policy; Institute Of Medicine; National Academy Of Sciences - Developing a National Registry of Pharmacologic and Biologic Clinical Trials - 9780309100786 - V9780309100786](/images/unavailable-full.jpg)
Developing a National Registry of Pharmacologic and Biologic Clinical Trials
Committee On Clinical Trial Registries; Board On Health Sciences Policy; Institute Of Medicine; National Academy Of Sciences
To improve public confidence in clinical research, a number of public and private groups have called for a publicly accessible, comprehensive, and transparent registry of relevant information on clinical trials for drugs and biologics. The public and various entities within the medical community (health care providers, researchers, medical journal editors, pharmaceutical companies, health insurers, and regulators) have different expectations and perceived needs regarding a public clinical trial registry.
The IOM Committee on Clinical Trial Registries hosted a workshop on June 27, 2005, to obtain much-needed input from members of the public, public advocate groups, and the broader ... Read more
- Front Matter
- 1 Summary
- 2 The Need for Clinical Trial Registries
- 3 Current Registry Activities
- 4 Content of a Clinical Trial Registry
- 5 Implementation Issues
- 6 Conclusion and Next Steps
- References
- Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005
- Appendix B Workshop Agenda, Speakers, Panelists, and Participants - June 27, 2005
- Appendix C Sec. 113 of the Food and Drug Administration Modernization Act of 1997; Guidance for Industry: Information Programs on Clinical Trials...
- Appendix D Published Journal Editorials
- Appendix E Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases
- Appendix F Illustrative Data Fields for the Results Summary
- Appendix G Biographical Sketches of Committee Members
Product Details
About Committee On Clinical Trial Registries; Board On Health Sciences Policy; Institute Of Medicine; National Academy Of Sciences
Reviews for Developing a National Registry of Pharmacologic and Biologic Clinical Trials